Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients
- 1 November 1984
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 4 (5), 884-889
- https://doi.org/10.1016/s0735-1097(84)80047-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performanceThe American Journal of Cardiology, 1984
- Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activityJournal of the American College of Cardiology, 1983
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Vasodilator therapy for acute myocardial infarction and chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Acute hemodynamic responses to vasodilator therapy in congestive heart failureProgress in Cardiovascular Diseases, 1982
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- The role of vasodilator therapy in heart failureProgress in Cardiovascular Diseases, 1977
- Thermodilution cardiac output determination with a single flow-directed catheterAmerican Heart Journal, 1972